Genetec Technology Berhad Beheer
Beheer criteriumcontroles 2/4
De CEO Genetec Technology Berhad is Kem Chin, benoemd in Oct1997, heeft een ambtstermijn van 27.08 jaar. De totale jaarlijkse vergoeding van { bedraagt MYR 994.42K, bestaande uit 105.1% salaris en -5.1% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 7.64% van de aandelen van het bedrijf, ter waarde MYR 48.87M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 15.1 jaar en 2.7 jaar.
Belangrijke informatie
Kem Chin
Algemeen directeur
RM 994.4k
Totale compensatie
| Percentage CEO-salaris | 105.1% |
| Dienstverband CEO | 27.1yrs |
| Eigendom CEO | 7.6% |
| Management gemiddelde ambtstermijn | 15.1yrs |
| Gemiddelde ambtstermijn bestuur | 2.7yrs |
Recente managementupdates
Recent updates
Genetec Technology Berhad (KLSE:GENETEC) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Oct 23
Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher
Sep 22Genetec Technology Berhad (KLSE:GENETEC) Analysts Are More Bearish Than They Used To Be
Aug 27Not Many Are Piling Into Genetec Technology Berhad (KLSE:GENETEC) Stock Yet As It Plummets 27%
Aug 19Is Genetec Technology Berhad (KLSE:GENETEC) A Risky Investment?
Aug 06Genetec Technology Berhad's (KLSE:GENETEC) P/E Still Appears To Be Reasonable
Feb 26Slowing Rates Of Return At Genetec Technology Berhad (KLSE:GENETEC) Leave Little Room For Excitement
Jan 15Genetec Technology Berhad's (KLSE:GENETEC) CEO Will Probably Have Their Compensation Approved By Shareholders
Sep 22Does Genetec Technology Berhad (KLSE:GENETEC) Deserve A Spot On Your Watchlist?
Feb 08Genetec Technology Berhad (KLSE:GENETEC) Is Investing Its Capital With Increasing Efficiency
Dec 28Does Genetec Technology Berhad (KLSE:GENETEC) Have A Healthy Balance Sheet?
Nov 17Investors Shouldn't Overlook Genetec Technology Berhad's (KLSE:GENETEC) Impressive Returns On Capital
Aug 16Genetec Technology Berhad (KLSE:GENETEC) Has A Pretty Healthy Balance Sheet
Jul 21Genetec Technology Berhad (KLSE:GENETEC) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 30Genetec Technology Berhad's (KLSE:GENETEC) Intrinsic Value Is Potentially 93% Above Its Share Price
Apr 28Why We Like The Returns At Genetec Technology Berhad (KLSE:GENETEC)
Mar 23Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly
Feb 24Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly
Nov 04The CEO Of Genetec Technology Berhad (KLSE:GENETEC) Might See A Pay Rise On The Horizon
Sep 08Genetec Technology Berhad's (KLSE:GENETEC) Robust Earnings Are Not All Good News For Shareholders
Aug 05Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher
Jul 30Is Genetec Technology Berhad (KLSE:GENETEC) Using Debt In A Risky Way?
Jun 11How Well Is Genetec Technology Berhad (KLSE:GENETEC) Allocating Its Capital?
Feb 10Why Genetec Technology Berhad's (KLSE:GENETEC) CEO Pay Matters
Jan 14Here's Why Genetec Technology Berhad (KLSE:GENETEC) Can Manage Its Debt Responsibly
Dec 24
Genetec Technology Berhad's (KLSE:GENETEC) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?
Dec 03Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | RM 994k | RM 1m | RM 69m |
| Mar 31 2024 | n/a | n/a | RM 76m |
| Dec 31 2023 | n/a | n/a | RM 69m |
| Sep 30 2023 | n/a | n/a | RM 59m |
| Jun 30 2023 | n/a | n/a | RM 66m |
| Mar 31 2023 | RM 965k | RM 829k | RM 50m |
| Dec 31 2022 | n/a | n/a | RM 70m |
| Sep 30 2022 | n/a | n/a | RM 75m |
| Jun 30 2022 | n/a | n/a | RM 67m |
| Mar 31 2022 | RM 952k | RM 827k | RM 56m |
| Dec 31 2021 | n/a | n/a | RM 37m |
| Sep 30 2021 | n/a | n/a | RM 20m |
| Jun 30 2021 | n/a | n/a | RM 6m |
| Mar 31 2021 | RM 947k | RM 821k | -RM 4m |
| Dec 31 2020 | n/a | n/a | -RM 6m |
| Sep 30 2020 | n/a | n/a | RM 1m |
| Jun 30 2020 | n/a | n/a | -RM 1m |
| Mar 31 2020 | RM 1m | RM 840k | -RM 166k |
| Dec 31 2019 | n/a | n/a | RM 4m |
| Sep 30 2019 | n/a | n/a | RM 469k |
| Jun 30 2019 | n/a | n/a | RM 981k |
| Mar 31 2019 | RM 1m | RM 851k | RM 6m |
| Dec 31 2018 | n/a | n/a | RM 10m |
| Sep 30 2018 | n/a | n/a | RM 8m |
| Jun 30 2018 | n/a | n/a | RM 6m |
| Mar 31 2018 | RM 1m | RM 865k | RM 4m |
Compensatie versus markt: De totale vergoeding ($USD 222.50K ) Kem } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de MY markt ($USD 107.97K ).
Compensatie versus inkomsten: De vergoeding van Kem is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Kem Chin (54 yo)
27.1yrs
Tenure
RM 994,416
Compensatie
Mr. Kem Weng Chin serves as the Managing Director of Genetec Technology Berhad since October 27, 1997 and serves as its Executive Director. Mr. Chin joined Applied Magnetics Malaysia Sdn Bhd (Disc Drive Re...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| MD & Executive Director | 27.1yrs | RM 994.42k | 7.64% MYR 48.9m | |
| COO & Executive Director | 15.1yrs | RM 849.14k | 1.49% MYR 9.5m | |
| Chief Financial Officer | 15.1yrs | geen gegevens | 1.64% MYR 10.5m | |
| Company Secretary | 14.1yrs | geen gegevens | geen gegevens |
15.1yrs
Gemiddelde duur
53yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van GENETEC is doorgewinterd en ervaren (gemiddelde ambtstermijn van 15.1 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| MD & Executive Director | no data | RM 994.42k | 7.64% MYR 48.9m | |
| COO & Executive Director | 6.1yrs | RM 849.14k | 1.49% MYR 9.5m | |
| Independent Non-Executive Director | 4.3yrs | RM 142.00k | 0.10% MYR 652.0k | |
| Independent Non-Executive Director | 2.7yrs | RM 90.00k | 0.013% MYR 81.5k | |
| Independent Non-Executive Director | 1.1yrs | RM 54.00k | geen gegevens | |
| Independent Non-Executive Chairman | 1.5yrs | RM 156.00k | 0.26% MYR 1.7m |
2.7yrs
Gemiddelde duur
54yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van GENETEC wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.7 jaar), wat duidt op een nieuw bestuur.